Naar de inhoud
AusGrant
EU Open EU-FUNDING-PORTAL-HORIZON-HLTH-2023-CARE-08-01

European Partnership on Personalised Medicine

European Commission (EC) · Competitief · Horizon Europe

In het kort

European Partnership on Personalised Medicine is een EU-brede subsidie van het type 'Competitief' van European Commission. Financiering: Tot €37M. Wie kan aanvragen: Open to eligible organisations in EU Member States and Horizon Europe associated countries; consortium requirements vary by topic - see the official call conditions. De aanvraagdeadline is 20 januari 2027. Dien in via de officiële vermelding op ec.europa.eu.

Bedrag
Tot €37M
Deadline
20 jan. 2027
Type
Competitief
Status
Open

Het programma

With this JTC, EP PerMed will fund research projects in human health on Cell and Gene Therapies (CGT) for PM approaches. Proposals must focus on the development and validation of an innovative and novel CGT for PM.At least one of the following approaches must be employed:Somatic cell therapeutics;Gene therapeutics;Combined cell- and gene therapeutics;Novel biological products.For the entire scope, please consult the Call Text: https://www.eppermed.eu/funding-projects/calls/jtc2027/.

Wie kan aanvragen

Open to eligible organisations in EU Member States and Horizon Europe associated countries; consortium requirements vary by topic - see the official call conditions.

Zo vraagt u aan

Apply through the EU Funding & Tenders portal; submission is electronic via the portal's Submission Service before the topic deadline.

Aanvragen via de officiële bron